Heard in Brussels

More Articles

Bio-People

More Bio-People

  • Finance and pharma experts

    25.07.2014 With the appointment of Ann-Tove Kongsnes and Hilde Furberg to its board of directors, Swedish specialty pharma company... more

  • Exec for orphan diseases

    12.07.2014 Will Lewis has joined Uniqure’s supervisory board in June 2014. The human gene therapy specialist company expects to... more

  • Drug developer

    08.07.2014 Swiss start-up Spinomix has added long-time investor Dr. K. Peter Hirth to its Board of Directors. more

  • Science advisors

    03.07.2014 British Ario Pharma Ltd has strengthened its scientific capacities by adding two research experts to its team:... more

Editorial

More Articles

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/people.html

Events

All Events

Stock list

All quotes

TOP

  • NOVACYT (F)4.98 EUR5.96%
  • STALLERGENES (F)53.50 EUR4.37%
  • SUMMIT (UK)4.03 GBP3.87%

FLOP

  • ANTISOMA (UK)1.32 GBP-14.84%
  • XENETIC BIOSCIENCES (UK)6.00 GBP-14.29%
  • THROMBOGENICS (B)9.54 EUR-5.07%

TOP

  • WILEX (D)3.15 EUR314.5%
  • SANTHERA (CH)68.55 CHF90.4%
  • ADDEX (CH)4.08 CHF82.1%

FLOP

  • MERCK KGAA (D)65.43 EUR-48.6%
  • HYBRIGENICS (F)1.77 EUR-29.2%
  • PROSENSA (NL)9.81 USD-22.6%

TOP

  • SANTHERA (CH)68.55 CHF3489.0%
  • GW PHARMACEUTICALS (UK)427.00 GBP729.1%
  • PAION (D)2.79 EUR316.4%

FLOP

  • CYTOS (CH)0.26 CHF-92.4%
  • EVOCUTIS (UK)0.21 GBP-91.8%
  • THROMBOGENICS (B)9.54 EUR-69.5%

No liability assumed, Date: 25.07.2014

Job Advert

Executive Director of the IMI Joint Undertaking

The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries Associations (EFPIA).
The Executive Director will lead and manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. more...


Current issue

All issues

Product of the week

Products